Though digital detailing isn’t new, it has certainly taken on new relevance post COVID-19. Forced to change, many digitisation projects were postponed indefinitely because they were considered too risky to be moved forward.
The traditional approach must shift from delivering promotions through a sales representative to managing a journey engaging HCPs and customers across diverse points of contact. Pharma companies must not only excel in product innovation; they also need to deliver on customer-centricity.
Download our report to discover how companies can reinvent detailing to drive growth.